Skip to content

Scheduled intravenous acetaminophen versus thoracic epidural analgesia for postoperative pain control after minimally invasive gastrectomy: a multicenter randomized non-inferiority trial

Scheduled intravenous acetaminophen versus thoracic epidural analgesia for postoperative pain control after minimally invasive gastrectomy: a multicenter randomized non-inferiority trial - Scheduled intravenous acetaminophen versus thoracic epidural analgesia for postoperative pain control after minimally invasive gastrectomy: a multicenter randomized non-inferiority trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039505
Enrollment
140
Registered
2020-03-05
Start date
2020-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Control group: The patient is placed under epidural anesthesia during surgery, and epidural anesthesia is used for postoperative analgesia. Intervention group: Wound local anesthesia is performed at

Sponsors

Gastrointestinal Cancer Conference study group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Histologically proven adenocarcinoma of the stomach 2) Surgically resectable tumor (cStageI-III) by laparoscopic gastrectomy 3) Age 20 > years 4) ECOG performance status 0 or 1. 5) Cases with adequately maintained organ functions and fullfilling the following conditions within 4 weeks before registration. WBC>3000 Plt>100000 AST<100 ALT<100 Total bilrbin<2.0mg/dL Serum creatinine<1.5mg/dL 6) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with synchronous or metachronous malignancies. 2) Inappropriate for epidural anesthesia 3) Patients with Hugh-Jones II or higher pulmonary disease 4) Unstable angina pectoris or history of myocardial infarction within 6 months. 5) Uncontrollable hypertension. 6) Uncontrollable diabetes mellitus 7) History of hypersensitivity of acetaminophen 8) History of hypersensitivity of ropivacaine hydrochloride hydrate or lidocaine hydrochloride 9) History of hypersensitivity of aspirin-induced asthma 10) Continuous systemic steroid therapy. 11) Women during pregnancy or breast feeding. 12) Judged inappropriate by the investigators

Design outcomes

Primary

MeasureTime frame
The proportion of patients with a resting NRS score of 4 or higher at 24 hours after surgery

Secondary

MeasureTime frame
1.Pain-related outcomes Area under the NRS-time curve during the first 72 hours (AUC72) Time course of NRS scores at rest and during coughing Number of rescue analgesic doses through POD3 Patient satisfaction assessed using a 7-point Likert scale (1-7) 2.Operative and anesthetic variables Operative time and anesthetic time 3.Postoperative recovery outcomes Time to first flatus and defecation Time to ambulation Time to urinary catheter removal Length of postoperative hospital stay 4.Safety outcomes Incidence and severity of analgesia-related adverse events Incidence and severity of postoperative surgical complications (Clavien-Dindo classification) Laboratory abnormalities, including hepatotoxicity, graded by CTCAE v4.0 5.Exploratory (post hoc) analyses Proportion of patients with an NRS score >=4 at rest (48 and 72 hours) and during coughing (24, 48, and 72 hours) (These exploratory analyses were added after study completion to ensure transparency and did not alter the study conduct or interpretation.)

Countries

Japan

Contacts

Public ContactJun Kinoshita

Kanazawa University Gastroenterologic Surgery

junkino0416@gmail.com076-265-2362

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026